Delivery Order SPE2DB22D1202-SPE2DB24FVEQ0
Award Date
6/24/24
Potential Completion Date
7/16/24
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BENLYSTA 120 MG vials, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,275.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $5,586.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 13, 2024. The contract is not designated as a set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024, with a ceiling value of $5,779.12 and a completion date of January 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $16,758.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, on October 8, 2024. The contract has an ultimate completion date of October 30, 2024 and is not set aside for any special business category. Amerisourcebergen has a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML. The firm-fixed-price contract has a ceiling value of $12,330.68 and an ultimate completion date of February 20, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price contract valued at $5,586.06. The contract has an ultimate completion date of July 30, 2024 and was awarded on July 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 1, 2024 with a ceiling value of $2,793.03. The contract has a firm fixed price pricing type and an ultimate completion date of July 23, 2024. This award is not associated with a set-aside program....
This federal contract award is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 6, 2025. The contract has a ceiling value of $30,826.70 and a completion date of January 28, 2025. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition....
This federal contract award, valued at $6,165.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BENLYSTA 200 MG/ML AUTOINJEC ML, a pharmaceutical product. The contract has a period of performance through February 13, 2025 and is structured as a firm fixed-price delivery order. This award does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 200 MG/ML AUTOINJECTML, a pharmaceutical product, to the Defense Logistics Agency (DLA) over a period ending on July 31, 2024. The firm-fixed-price contract has a ceiling value of $8,379.09. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...